Alternative splicing modulates subcellular localization of laforin
- PMID: 11883934
- DOI: 10.1006/bbrc.2002.6590
Alternative splicing modulates subcellular localization of laforin
Abstract
Laforin is a dual-specificity phosphatase coded by the EPM2A gene defective in Lafora's progressive myoclonus epilepsy. We reported earlier that laforin is a cytoplasmic protein associated primarily with polyribosome. In the present study we characterized the expression of an EPM2A splice variant, named C-terISO, originating from the usage of a novel exon located in the 3'-untranslated region of exon 4 and encoding a laforin isoform containing unique sequences at its carboxyl terminus. Transfection studies demonstrate that, in addition to cytoplasm, the protein coded by C-terISO was targeted to the nucleus, a distinctive feature that was not observed for laforin coded by the major transcript of the EPM2A gene. The unique C-terminal sequence did not affect laforin's affinity for polysome, but sequestered nearly an equal amount of the protein into the nucleus. Our results are significant in light of the finding that laforin is an active phosphatase; therefore, isoforms targeted to different cellular compartments might dephosphorylate and regulate distinct cellular substrates.
(C)2002 Elsevier Science (USA).
Similar articles
-
Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.Hum Mol Genet. 2002 May 15;11(11):1263-71. doi: 10.1093/hmg/11.11.1263. Hum Mol Genet. 2002. PMID: 12019207
-
Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy.Neurology. 2000 Aug 8;55(3):341-6. doi: 10.1212/wnl.55.3.341. Neurology. 2000. PMID: 10932264
-
Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes.Hum Mol Genet. 2000 Sep 22;9(15):2251-61. doi: 10.1093/oxfordjournals.hmg.a018916. Hum Mol Genet. 2000. PMID: 11001928
-
Lafora's disease: towards a clinical, pathologic, and molecular synthesis.Pediatr Neurol. 2001 Jul;25(1):21-9. doi: 10.1016/s0887-8994(00)00276-9. Pediatr Neurol. 2001. PMID: 11483392 Review.
-
[Molecular genetics of epilepsy].Rinsho Shinkeigaku. 2004 Nov;44(11):858-60. Rinsho Shinkeigaku. 2004. PMID: 15651314 Review. Japanese.
Cited by
-
A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.Genes Dev. 2007 Oct 1;21(19):2399-409. doi: 10.1101/gad.1553207. Genes Dev. 2007. PMID: 17908927 Free PMC article.
-
ACBD2/ECI2-Mediated Peroxisome-Mitochondria Interactions in Leydig Cell Steroid Biosynthesis.Mol Endocrinol. 2016 Jul;30(7):763-82. doi: 10.1210/me.2016-1008. Epub 2016 May 11. Mol Endocrinol. 2016. PMID: 27167610 Free PMC article.
-
Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy.J Hum Genet. 2006;51(1):1-8. doi: 10.1007/s10038-005-0321-1. Epub 2005 Nov 26. J Hum Genet. 2006. PMID: 16311711 Review.
-
Lafora disease: from genotype to phenotype.J Genet. 2018 Jul;97(3):611-624. J Genet. 2018. PMID: 30027899 Review.
-
Late-onset Lafora disease with prominent parkinsonism due to a rare mutation in EPM2A.Neurol Genet. 2016 Aug 16;2(5):e101. doi: 10.1212/NXG.0000000000000101. eCollection 2016 Oct. Neurol Genet. 2016. PMID: 27574708 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
